Leave Your Message

News

2023 ASH Opening | Dr. Peihua Lu Presents CAR-T for Relapsed /Refractory AML Research

2023 ASH Opening | Dr. Peihua Lu Presents CAR-T for Relapsed /Refractory AML Research

2024-04-09
A phase I clinical study of CD7 CAR-T for R/R AML by Daopei Lu's team debuts at ASHThe 65th Annual Meeting of the American Society of Hematology (ASH) was held offline (San Diego, USA) and online on December 9-12, 2023.Our scholars made a great show of this co...
view detail
ASH 2023|"The Voice of Lu Daopei" sings on the international stage

ASH 2023|"The Voice of Lu Daopei" sings on the international stage

2024-04-09
The American Society of Hematology (ASH) is the top academic meeting in the field of haematology worldwide. The fact that Lu Daopei Hospital has been selected as a finalist for the ASH for consecutive years fully demonstrates its academic achievements in the f...
view detail
ASH Voice of China| Professor Xian Zhang: High Efficacy And Safety of Nanobody Based Anti-BCMA CAR-T Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

ASH Voice of China| Professor Xian Zhang: High Efficacy And Safety of Nanobody Based Anti-BCMA CAR-T Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

2024-04-09
The 65th Annual Meeting of the American Society of Hematology (ASH) was held from 9 to 12 December 2023, in San Diego, USA. As the world's largest and most comprehensive hematology top academic event, it attracts thousands of experts and scholars from all over...
view detail